Market TodayThemes and Stocks SummaryThematic Stock SearchDaily Refresh Schedule
YMAB - Y-Mabs Therapeutics Inc
0.55(1.56%)9:00:00 PM 3/1/2021
Y-mAbs Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody-based therapeutic products for the treatment cancer in the United States. The company develops naxitamab that is in Phase 2 clinical trial for the treatment of pediatric patients with relapsed steosarcoma or refractory, and high-risk neuroblastoma, as well as other GD2 positive tumors; and GD2-GD3 Vaccine which is in Phase 2 clinical trial for the treatment of high-risk neuroblastoma. It is developing omburtamab that is in Phase 2 clinical trial for the treatment of desmoplastic small round cell tumors; in Phase 1 clinical trial for the treatment of diffuse intrinsic pontine glioma, as well as for the treatment of pediatric patients with central nervous system and leptomeningeal metastases; The company also engages in the development of huB7-H3 product candidate for the treatment of B7-H3 positive adult solid tumors; and pre clinical development of huCD33 BsAb product candidate for the treatment of huCD33 positive hermatological cancers. The company has a license and research collaboration agreement with Memorial Sloan Kettering Cancer Center and Massachusetts Institute of Technology to develop and commercialize antibody constructs based on the SADA-BiDE pre-targeted radioimmunotherapy platform. Y-mAbs Therapeutics, Inc. was founded in 2015 and is headquartered in New York, New York.
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 


Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.


  • Volatility is at a recent 2 week high. A high volatility of stock movement indicates uncertainty.
Stock Statistics
PE Ratio
PEG Ratio0.3
P/S (ttm)73.7
Earning Growth (QoQ)
Revenue Growth (QoQ)
Short %7%
Held by Institutions %61%
1 Day Vol Adjusted Return0.4
1 Month Vol Adjusted Return-4.4
3 Month Vol Adjusted Return-6.0
6 Month Vol Adjusted Return-4.4
20 Days SMA Price ZScore-1.5
50 Days SMA Price ZScore-2.1
12 -26 Days PPO-7.2
1 Month Average Short Volume Ratio51.3
1 Day Volume Change ZScore-0.5
1 Month Daily Vol3.7
Related Topics
leak data

Related Topics


Related Peers

Stock news